Exosome engineering for efficient and targeted drug delivery: Current status and future perspective
- PMID: 35570717
- DOI: 10.1113/JP282799
Exosome engineering for efficient and targeted drug delivery: Current status and future perspective
Abstract
Exosomes are membrane-bound vesicles that are released by most cells. They carry nucleic acids, cytokines, growth factors, proteins, lipids, and metabolites. They are responsible for inter- and intracellular communications and their role in drug delivery is well defined. Exosomes have great potential for therapeutic applications, but the clinical use is restricted because of limitations in standardized procedures for isolation, purification, and drug delivery. Bioengineering of exosomes could be one approach to achieve standardization and reproducible isolation for clinical use. Exosomes are important transporters for targeted drug delivery because of their small size, stable structure, non-immunogenicity, and non-toxic nature, as well as their ability to carry a wide variety of compounds. These features of exosomes can be enhanced further by bioengineering. In this review, possible exosome bioengineering approaches, their biomedical applications, and targeted drug delivery are discussed.
Keywords: bioengineering; drug cargo; exosome; exosome-modification; extracellular vesicles.
© 2022 The Authors. The Journal of Physiology © 2022 The Physiological Society.
References
-
- Adem, B., Vieira, P. F., & Melo, S. A. (2020). Decoding the biology of exosomes in metastasis. Trends in Cancer, 6(1), 20-30.
-
- Akbar, A., Malekian, F., Baghban, N., Kodam, S. P., & Ullah, M. (2022). Methodologies to isolate and purify clinical grade extracellular vesicles for medical applications. Cells, 11(2), 186.
-
- Akbar, A., Pillalamarri, N., Jonnakuti, S., & Ullah, M. (2021). Artificial intelligence and guidance of medicine in the bubble. Cell & Bioscience, 11, 108.
-
- Akuma, P., Okagu, O. D., & Udenigwe, C. C. (2019). Naturally occurring exosome vesicles as potential delivery vehicle for bioactive compounds. Frontiers in Sustainable Food Systems, 3, 23.
-
- Altanerova, U., Babincova, M., Babinec, P., Benejova, K., Jakubechova, J., Altanerova, V., Zduriencikova, M., Repiska, V., & Altaner, C. (2017). Human mesenchymal stem cell-derived iron oxide exosomes allow targeted ablation of tumor cells via magnetic hyperthermia. International Journal of Nanomedicine, 12, 7923.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources